Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance
- PMID: 29362454
- PMCID: PMC5780381
- DOI: 10.1038/s41598-018-19753-9
Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance
Abstract
This study aimed to determine if there is an association between dysbiosis and nonalcoholic fatty liver disease (NAFLD) independent of obesity and insulin resistance (IR). This is a prospective cross-sectional study assessing the intestinal microbiome (IM) of 39 adults with biopsy-proven NAFLD (15 simple steatosis [SS]; 24 nonalcoholic steatohepatitis [NASH]) and 28 healthy controls (HC). IM composition (llumina MiSeq Platform) in NAFLD patients compared to HC were identified by two statistical methods (Metastats, Wilcoxon). Selected taxa was validated using quantitative PCR (qPCR). Metabolites in feces and serum were also analyzed. In NAFLD, 8 operational taxonomic units, 6 genera, 6 families and 2 phyla (Bacteroidetes, Firmicutes) were less abundant and; 1 genus (Lactobacillus) and 1 family (Lactobacillaceae) were more abundant compared to HC. Lower abundance in both NASH and SS patients compared to HC were confirmed by qPCR for Ruminococcus, Faecalibacterium prausnitzii and Coprococcus. No difference was found between NASH and SS. This lower abundance in NAFLD (NASH+SS) was independent of BMI and IR. NAFLD patients had higher concentrations of fecal propionate and isobutyric acid and serum 2-hydroxybutyrate and L-lactic acid. These findings suggest a potential role for a specific IM community and functional profile in the pathogenesis of NAFLD.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.Hepatology. 2016 Mar;63(3):764-75. doi: 10.1002/hep.28356. Epub 2016 Jan 13. Hepatology. 2016. PMID: 26600078 Free PMC article.
-
Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan.Nutrients. 2020 Mar 19;12(3):820. doi: 10.3390/nu12030820. Nutrients. 2020. PMID: 32204538 Free PMC article.
-
Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.Hepatobiliary Pancreat Dis Int. 2017 Aug 15;16(4):375-381. doi: 10.1016/S1499-3872(17)60019-5. Hepatobiliary Pancreat Dis Int. 2017. PMID: 28823367
-
Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.Biomolecules. 2021 Dec 31;12(1):56. doi: 10.3390/biom12010056. Biomolecules. 2021. PMID: 35053205 Free PMC article. Review.
-
Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease.Aliment Pharmacol Ther. 2015 Nov;42(9):1051-63. doi: 10.1111/apt.13376. Epub 2015 Aug 24. Aliment Pharmacol Ther. 2015. PMID: 26304302 Review.
Cited by
-
An update on the role of the microbiome in non-alcoholic fatty liver disease pathogenesis, diagnosis, and treatment.Curr Treat Options Gastroenterol. 2020 Jun;18(2):270-280. doi: 10.1007/s11938-020-00290-2. Epub 2020 May 2. Curr Treat Options Gastroenterol. 2020. PMID: 33716495 Free PMC article.
-
Impact of Altered Gut Microbiota and Its Metabolites in Cystic Fibrosis.Metabolites. 2021 Feb 22;11(2):123. doi: 10.3390/metabo11020123. Metabolites. 2021. PMID: 33671639 Free PMC article. Review.
-
Research Progress on the Therapeutic Effect of Polysaccharides on Non-Alcoholic Fatty Liver Disease through the Regulation of the Gut-Liver Axis.Int J Mol Sci. 2022 Oct 3;23(19):11710. doi: 10.3390/ijms231911710. Int J Mol Sci. 2022. PMID: 36233011 Free PMC article. Review.
-
Altered gut microbial profile accompanied by abnormal short chain fatty acid metabolism exacerbates nonalcoholic fatty liver disease progression.Sci Rep. 2024 Sep 27;14(1):22385. doi: 10.1038/s41598-024-72909-8. Sci Rep. 2024. PMID: 39333290 Free PMC article.
-
Development of non-alcoholic steatohepatitis is associated with gut microbiota but not with oxysterol enzymes CH25H, EBI2, or CYP7B1 in mice.BMC Microbiol. 2024 Feb 28;24(1):69. doi: 10.1186/s12866-024-03195-7. BMC Microbiol. 2024. PMID: 38418983 Free PMC article.
References
-
- Younossi, Z. M. et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol9, 524–530.e521; quiz e560, 10.1016/j.cgh.2011.03.020 (2011). - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical